# Estrella Immunopharma, Inc.: Form 10-K/A for the period ended Jun 30, 2024

- Company: [Estrella Immunopharma, Inc.](/companies/esla.md) (CIK 1844417)
- Form: 10-K/A
- Filed: 2024-10-28
- Accepted by EDGAR: Oct 28, 2024, 17:03 ET
- Period: 2024-06-30
- Accession: 0001213900-24-091250
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1844417/000121390024091250/ea0218384-10ka1_estrella.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1844417/000121390024091250/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1844417/000121390024091250/ea0218384-10ka1_estrella.htm

Filed Oct 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-091250. Last ingested by Listed: Nov 4, 2026, 07:37 ET. No prices; not investment advice.
